Annual Cash & Cash Equivalents
$430.61 M
+$411.40 M+2142.15%
December 1, 2024
Summary
- As of March 10, 2025, JANX annual cash & cash equivalents is $430.61 million, with the most recent change of +$411.40 million (+2142.15%) on December 1, 2024.
- During the last 3 years, JANX annual cash & cash equivalents has risen by +$395.02 million (+1110.18%).
- JANX annual cash & cash equivalents is now at all-time high.
Performance
JANX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$430.61 M
+$403.85 M+1509.50%
December 1, 2024
Summary
- As of March 10, 2025, JANX quarterly cash and cash equivalents is $430.61 million, with the most recent change of +$403.85 million (+1509.50%) on December 1, 2024.
- Over the past year, JANX quarterly cash and cash equivalents has stayed the same.
- JANX quarterly cash and cash equivalents is now at all-time high.
Performance
JANX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
JANX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2142.2% | 0.0% |
| 3 y3 years | +1110.2% | 0.0% |
| 5 y5 years | +10000.0% | 0.0% |
JANX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2142.2% | at high | +2836.9% |
| 5 y | 5-year | at high | >+9999.0% | at high | +5411.4% |
| alltime | all time | at high | >+9999.0% | at high | +5411.4% |
Janux Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $430.61 M(+2142.2%) | $430.61 M(+1509.5%) |
| Sep 2024 | - | $26.75 M(+82.5%) |
| Jun 2024 | - | $14.66 M(-93.1%) |
| Mar 2024 | - | $212.80 M(+1008.1%) |
| Dec 2023 | $19.20 M(-62.7%) | $19.20 M(+12.0%) |
| Sep 2023 | - | $17.15 M(-49.1%) |
| Jun 2023 | - | $33.70 M(+11.0%) |
| Mar 2023 | - | $30.36 M(-41.0%) |
| Dec 2022 | $51.43 M | $51.43 M(-20.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $64.75 M(+10.9%) |
| Jun 2022 | - | $58.40 M(+5.9%) |
| Mar 2022 | - | $55.13 M(+54.9%) |
| Dec 2021 | $35.58 M(+355.4%) | $35.58 M(-9.7%) |
| Sep 2021 | - | $39.39 M(-84.3%) |
| Jun 2021 | - | $251.63 M(+255.6%) |
| Mar 2021 | - | $70.77 M(+805.8%) |
| Dec 2020 | $7.81 M(+1087.4%) | $7.81 M |
| Dec 2019 | $658.00 K | - |
FAQ
- What is Janux Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Janux Therapeutics?
- What is Janux Therapeutics annual cash & cash equivalents year-on-year change?
- What is Janux Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Janux Therapeutics?
- What is Janux Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Janux Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of JANX is $430.61 M
What is the all time high annual cash & cash equivalents for Janux Therapeutics?
Janux Therapeutics all-time high annual cash & cash equivalents is $430.61 M
What is Janux Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, JANX annual cash & cash equivalents has changed by +$411.40 M (+2142.15%)
What is Janux Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of JANX is $430.61 M
What is the all time high quarterly cash and cash equivalents for Janux Therapeutics?
Janux Therapeutics all-time high quarterly cash and cash equivalents is $430.61 M
What is Janux Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, JANX quarterly cash and cash equivalents has changed by $0.00 (0.00%)